KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Other financing activities (2016 - 2025)

National Health Investors filings provide 15 years of Other financing activities readings, the most recent being $72000.0 for Q4 2025.

  • On a quarterly basis, Other financing activities fell 93.45% to $72000.0 in Q4 2025 year-over-year; TTM through Mar 2026 was $3.8 million, a 215.04% increase, with the full-year FY2025 number at $3.9 million, up 231.71% from a year prior.
  • Other financing activities hit $72000.0 in Q4 2025 for National Health Investors, down from $3.8 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $20.6 million in Q2 2022 to a low of -$8.8 million in Q1 2022.
  • Median Other financing activities over the past 5 years was $58500.0 (2024), compared with a mean of $319812.5.
  • Biggest five-year swings in Other financing activities: tumbled 34400.0% in 2021 and later surged 5261.43% in 2025.
  • National Health Investors' Other financing activities stood at -$4.5 million in 2021, then dropped by 1.84% to -$4.5 million in 2022, then skyrocketed by 39.51% to -$2.7 million in 2023, then surged by 140.04% to $1.1 million in 2024, then crashed by 93.45% to $72000.0 in 2025.
  • The last three reported values for Other financing activities were $72000.0 (Q4 2025), $3.8 million (Q3 2025), and $9000.0 (Q2 2025) per Business Quant data.